DM
CRL icon

Deerfield Management’s Charles River Laboratories CRL Stock Holding History

Deerfield Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-43
Closed -$6.52K – 155
2025
Q2 		$6.52K Buy
+43
New +$5.73K ﹤0.01% 122
2024
Q4 		– Sell
-2,204
Closed -$434K – 186
2024
Q3 		$434K Buy
+2,204
New +$458K 0.01% 311
2016
Q1 		– Sell
-377,188
Closed -$30.3M – 109
2015
Q4 		$30.3M Sell
377,188
-204,000
-35% -$14.7M 1.23% 31
2015
Q3 		$36.9M Sell
581,188
-30,248
-5% -$2.17M 1.43% 21
2015
Q2 		$43M Buy
611,436
+321,986
+111% +$23.8M 1.43% 18
2015
Q1 		$22.9M Buy
+289,450
New +$21.4M 0.74% 35

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deerfield Management's CRL Position: Q3 2025 in Review

Deerfield Management sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 43 shares — an estimated $6.52K sold.

Deerfield Management first reported a position in CRL in Q1 2015 and held it in 6 quarters. The position peaked at $43M in Q2 2015. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Deerfield Management reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Deerfield Management sold 43 Charles River Laboratories shares in Q3 2025, an estimated $6.52K.
  • Deerfield Management first reported a position in Charles River Laboratories in Q1 2015 and held it in 6 quarters.
  • Deerfield Management's Charles River Laboratories position peaked at $43M in Q2 2015.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Deerfield Management's 13F filing for Q3 2025, filed 14 Nov 2025.